Sharafi Parisa, Akyol Mesut, Gultekin Ebrar, Sakar Rohat, Ardicoglu Akisin N Yasemin, Gocmen J Sedef
Department of Medical Biology, Faculty of Medicine, TOBB University of Economics and Technology, Söğütözü Cad. No:43, Söğütözü, 06500, Ankara, Turkey.
Department of Biostatistics and Medical Informatics, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey.
Sci Rep. 2025 Jul 29;15(1):27545. doi: 10.1038/s41598-025-91154-1.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the COVID-19 pandemic to break out touched off a global health catastrophe characterized by various degrees of disease severity among those who were afflicted. Many strategies, such as vitamin C administration, have been investigated to reduce COVID-19 symptoms. Although the exact processes by which vitamin C affects COVID-19 remain unclear, noticeable changes in PCR test results were noted in our laboratory settings. This study uses PCR analysis to investigate the effects of varying vitamin C dosages and durations on COVID-19 test results. PCR cycle threshold (Ct) values were used to categorize nasopharyngeal tissues from 98 patients (Ct < 30, Ct ≥ 30, negative). Vitamin C was applied at different concentrations (0, 1, 10, 50, and 100 mg/ml), and PCR analyses were carried out at 1, 10, 24, and 48 h marks after the vitamin was applied. Particularly in samples with lower Ct values, the data showed significant changes in the reaction graphs and metrics with increasing vitamin C concentration. Higher concentrations of vitamin C were correlated with diminished metrics, occasionally leading to negative results for samples with Ct ≥ 30 values. Notably, samples that showed no discernible viral loads had different pictorial representations. These results raise questions regarding the reliability of PCR results in the presence of vitamin C intake and have implications for COVID-19 diagnosis. In light of the current pandemic, more studies are necessary to confirm and expand these findings and provide a critical understanding of clinical procedures and the interpretation of test results.
导致新冠疫情爆发的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发了一场全球健康灾难,其特征是在感染者中出现不同程度的疾病严重程度。人们研究了许多策略,如服用维生素C,以减轻新冠症状。尽管维生素C影响新冠的具体过程尚不清楚,但在我们的实验室环境中,PCR检测结果出现了明显变化。本研究使用PCR分析来探究不同剂量和持续时间的维生素C对新冠检测结果的影响。PCR循环阈值(Ct)值被用于对98名患者的鼻咽组织进行分类(Ct<30、Ct≥30、阴性)。以不同浓度(0、1、10、50和100mg/ml)应用维生素C,并在应用维生素后的1、10、24和48小时进行PCR分析。特别是在Ct值较低的样本中,数据显示随着维生素C浓度的增加,反应图和指标有显著变化。较高浓度的维生素C与指标降低相关,偶尔会导致Ct≥30值的样本出现阴性结果。值得注意的是,显示不出明显病毒载量的样本有不同的图像表现。这些结果引发了关于在摄入维生素C的情况下PCR结果可靠性的问题,并对新冠诊断有影响。鉴于当前的疫情,需要更多研究来证实和扩展这些发现,并对临床程序和检测结果的解读提供关键认识。